Clinical Trial Update: Aβ Dynamics in LLMD [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating beta-amyloid dynamics in late-life major depressive disorder and Alzheimer's disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Major Depressive Disorder

Snippet

Sponsor: NYU Langone Health | Conditions: Alzheimer Disease, Major Depressive Disorder | Phase 4 | Status: RECRUITING